Mieke Zwager

Mieke Zwager is a researcher at the University of Groningen specializing in breast cancer pathology and digital image analysis. Her work focuses on tumor microenvironment dynamics, immune responses, and biomarker validation, contributing significantly to precision oncology through high-impact publications in pathology and cancer research journals.

Her primary research areas include breast cancer diagnostics, digital pathology algorithms, tumor-immune interactions, and molecular biomarkers. She employs advanced techniques like immunohistochemistry and computational image analysis to investigate Ki67 hotspot detection, Cyclin E1 signaling pathways, and adipose tissue microstructures in relation to cancer progression and genetic risk factors.

Recent publications (2024-2025) reveal a concentrated effort on integrating digital pathology with immunological profiling in breast cancer. Key themes include algorithmic optimization for biomarker quantification, interferon signaling in antitumor immunity, genomic instability-immune infiltration correlations, and metabolic imaging in metastatic disease. Her collaborative work through the IMPACT-Metastatic Breast Consortium demonstrates translational research bridging histopathology and nuclear medicine.

Dr. Zwager operates within the University Medical Center Groningen's oncology research ecosystem, collaborating with multidisciplinary teams of pathologists, medical oncologists, and molecular biologists to advance breast cancer diagnostics and therapeutic strategies.